Agile Therapeutics
AGRX
#10915
Rank
A$15.52 M
Marketcap
A$2.25
Share price
0.00%
Change (1 day)
306.50%
Change (1 year)

Earnings for Agile Therapeutics (AGRX)

Earnings in 2024 (TTM): -A$22.37 Million

According to Agile Therapeutics 's latest financial reports the company's current earnings are A$21.56 Million. In 2023 the company made an earning of -A$19.43 Million a decrease over its 2022 earnings that were of -A$7.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agile Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$22.37 Million15.13%
2023 -A$19.43 Million172.57%
2022 -A$7.13 Million-93.26%
2021 -A$0.11 Billion45.62%
2020 -A$72.58 Million161.98%
2019 -A$27.71 Million-2.78%
2018 -A$28.5 Million-27.47%
2017 -A$39.29 Million-10.16%
2016 -A$43.73 Million-14.2%
2015 -A$50.97 Million88.45%
2014 -A$27.05 Million41.72%
2013 -A$19.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.87 B-124,690.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.37 B-46,472.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.00 B-44,842.45%๐Ÿ‡บ๐Ÿ‡ธ USA
TherapeuticsMD
TXMD
A$0.17 M-100.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$98.09 M-538.45%๐Ÿ‡บ๐Ÿ‡ธ USA